MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

Search

Teleflex Inc

Gesloten

SectorGezondheidszorg

105.06 2.09

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

102

Max

106.74

Belangrijke statistieken

By Trading Economics

Inkomsten

-531M

-409M

Verkoop

132M

913M

K/W

Sectorgemiddelde

28.636

89.037

Dividendrendement

1.3

Winstmarge

-44.785

Werknemers

14,100

EBITDA

-546M

-323M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+29.37% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.30%

2.18%

Volgende Winsten

26 feb 2026

Volgende dividenddatum

16 mrt 2026

Volgende Ex Dividend datum

6 mrt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-877M

4.6B

Vorige openingsprijs

102.97

Vorige sluitingsprijs

105.06

Nieuwssentiment

By Acuity

50%

50%

174 / 360 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

Teleflex Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 jan 2026, 21:55 UTC

Winsten

Capital One Financial Posts Higher 4Q Profit As Lending Increases

22 jan 2026, 23:52 UTC

Winsten

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

22 jan 2026, 23:48 UTC

Marktinformatie

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

22 jan 2026, 23:42 UTC

Marktinformatie

Gold Edges Lower on Possible Profit-Taking -- Market Talk

22 jan 2026, 23:40 UTC

Marktinformatie

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

22 jan 2026, 23:30 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

22 jan 2026, 23:30 UTC

Marktinformatie

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

22 jan 2026, 22:37 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

22 jan 2026, 21:59 UTC

Acquisities, Fusies, Overnames

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

22 jan 2026, 21:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

22 jan 2026, 21:44 UTC

Winsten

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

22 jan 2026, 21:32 UTC

Acquisities, Fusies, Overnames

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

22 jan 2026, 21:31 UTC

Acquisities, Fusies, Overnames

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

22 jan 2026, 21:31 UTC

Acquisities, Fusies, Overnames

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

22 jan 2026, 21:30 UTC

Acquisities, Fusies, Overnames

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

22 jan 2026, 21:30 UTC

Winsten

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

22 jan 2026, 21:30 UTC

Acquisities, Fusies, Overnames

Capital One To Acquire Brex >COF

22 jan 2026, 21:13 UTC

Winsten

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

22 jan 2026, 21:11 UTC

Winsten

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 jan 2026, 21:11 UTC

Winsten

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 jan 2026, 21:10 UTC

Winsten

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 jan 2026, 21:06 UTC

Winsten

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

22 jan 2026, 21:05 UTC

Winsten

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

22 jan 2026, 21:05 UTC

Winsten

Capital One 4Q Rev $15.58B >COF

22 jan 2026, 21:05 UTC

Winsten

Capital One 4Q EPS $3.26 >COF

22 jan 2026, 21:05 UTC

Winsten

Capital One 4Q Net Interest Margin 8.26% >COF

22 jan 2026, 21:05 UTC

Winsten

Capital One 4Q Net $2.13B >COF

22 jan 2026, 21:05 UTC

Winsten

Capital One 4Q Adj EPS $3.86 >COF

22 jan 2026, 21:05 UTC

Winsten

Capital One 4Q Net Charge-Offs $3.8B >COF

22 jan 2026, 21:05 UTC

Winsten

Intuitive Surgical 4Q EPS $2.21 >ISRG

Peer Vergelijking

Prijswijziging

Teleflex Inc Prognose

Koersdoel

By TipRanks

29.37% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 133.2 USD  29.37%

Hoogste 155 USD

Laagste 115 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Teleflex Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

7 ratings

1

Buy

5

Hold

1

Sell

Technische score

By Trading Central

122.73 / 135.75Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

No Evidence

Sentiment

By Acuity

174 / 360 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Teleflex Inc

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
help-icon Live chat